British Journal of Dermatology
A string of (clinical) pearls about drug-induced linear IgA disease
Dyeing for a “new” topical agent for psoriasis? Think indigo
Prolactin and its role in stress-induced psoriasis: Milking the data
Brentuximab vedotin update and the #MeToo saga of the Reed-Sternberg cell
Incretin-based therapy for diabetes and dermatology: Promise and peril
Scratching below the surface for the etiology of nichen amyloidosis – no sweat?
Untangling the neurologic comorbidities of bullous pemphigoid
Vitiligo or vitiligo-like lesions and PD1-inhibitors: Which is right?
Frontal fibrosing alopecia: Bewitched, bothered, and bewildered
Risk factors for herpes zoster: Age, immunosuppression, and…statins?
Hidradenitis suppurativa and socioeconomic status: Food for thought (and benefit)
Learning about proton pump inhibitor-induced dermatologic adverse reactions is ulcerogenic
All content found on Dermatology World Insights and Inquiries, including: text, images, video, audio, or other formats, were created for informational purposes only. The content represents the opinions of the authors and should not be interpreted as the official AAD position on any topic addressed. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment.
DW Insights and Inquiries archive
Explore hundreds of Dermatology World Insights and Inquiries articles by clinical area, specific condition, or medical journal source.
All content solely developed by the American Academy of Dermatology
The American Academy of Dermatology gratefully acknowledges the support from Incyte Dermatology.
